Squire Investment Management Company’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$220K Buy
2,398
+23
+1% +$2.01K 0.05% 85
2026
Q1
$202K Sell
2,375
-370
-13% -$33K 0.06% 75
2025
Q4
$217K Buy
2,745
+50
+2% +$3.92K 0.07% 71
2025
Q3
$215K Sell
2,695
-28
-1% -$2.39K 0.07% 67
2025
Q2
$248K Sell
2,723
-17
-0.6% -$1.55K 0.09% 62
2025
Q1
$257K Buy
2,740
+67
+3% +$6K 0.11% 60
2024
Q4
$243K Buy
2,673
+3
+0.1% +$286 0.11% 63
2024
Q3
$277K Sell
2,670
-5,440
-67% -$554K 0.13% 55
2024
Q2
$787K Hold
8,110
0.45% 31
2024
Q1
$730K Hold
8,110
0.46% 32
2023
Q4
$646K Buy
+8,110
New +$610K 0.53% 32

Other funds holding CL

Squire Investment Management Company's CL Position: Q2 2026 in Review

Squire Investment Management Company increased its Colgate-Palmolive (CL) stake by 0.97% in Q2 2026, buying an estimated $2.01K and bringing the position to 2,398 shares worth $220K. The position accounts for 0.05% of the portfolio, ranked #85.

Squire Investment Management Company first reported a position in CL in Q4 2023 and has held it in 11 quarters since. The position peaked at $787K in Q2 2024. 895 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Squire Investment Management Company held 2,398 shares of Colgate-Palmolive worth $220K as of Q2 2026.
  • Squire Investment Management Company bought 23 Colgate-Palmolive shares in Q2 2026, an estimated $2.01K.
  • Colgate-Palmolive made up 0.05% of Squire Investment Management Company's portfolio in Q2 2026, its #85 holding.
  • Squire Investment Management Company first reported a position in Colgate-Palmolive in Q4 2023 and has held it in 11 quarters since.
  • Squire Investment Management Company's Colgate-Palmolive position peaked at $787K in Q2 2024.
  • 895 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Squire Investment Management Company's 13F filing for Q2 2026, filed 28 Jul 2026.